Filter
832
Filtered Results: 832
Text search:
in
vitro
Featured
Recommendations
100
New Publications
147
Language
Document type
No document type
336
Guidelines
236
Studies & Reports
123
Manuals
70
Fact sheets
26
Strategic & Response Plan
24
Training Material
9
Situation Updates
4
Resource Platforms
3
Brochures
1
Countries / Regions
India
32
Latin America and the Carribbean
26
Germany
23
Russia
23
South Africa
20
Brazil
17
Global
17
Africa
13
Colombia
11
Western and Central Europe
11
Argentina
10
Kenya
9
Peru
9
Ethiopia
8
Zambia
8
Bolivia
8
Paraguay
8
Eastern Europe
7
Rwanda
6
Namibia
6
Ukraine
6
Venezuela
6
Burkina Faso
5
Uganda
5
Tanzania
5
Indonesia
5
El Salvador
5
Nigeria
4
Senegal
4
Cameroon
4
West and Central Africa
4
Middle East and North Africa
4
Sierra Leone
3
Congo, Democratic Republic of
3
Mali
3
Niger
3
Nepal
3
Benin
3
Eswatini/ Swaziland
3
Ecuador
3
Lesotho
3
Myanmar / Burma
3
East and Southern Africa
3
Eastern Europe and Central Asia
3
Congo-Brazzaville
3
France
3
Spain
3
Guinea
2
Liberia
2
Côte d’Ivoire / Ivory Coast
2
Haiti
2
Philippines
2
Syria
2
Chad
2
Bangladesh
2
Malawi
2
Angola
2
Madagascar
2
Chile
2
Yemen
2
Asia
2
Tajikistan
2
Kazakhstan
2
Guinea-Bissau
1
Morocco
1
USA
1
Saudi Arabia
1
Ghana
1
Togo
1
Zimbabwe
1
Somalia
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Turkey
1
Egypt
1
Thailand
1
Gambia
1
Mauritania
1
Mozambique
1
Sudan
1
Dominican Republic
1
North Macedonia
1
Serbia
1
Cuba
1
Burundi
1
Honduras
1
Libya
1
Guatemala
1
Mexico
1
Nicaragua
1
South–East Asia Region
1
Luxembourg
1
Albania
1
Djibouti
1
Armenia
1
Mongolia
1
Southern Africa
1
Laos
1
Canada
1
Qatar
1
Uzbekistan
1
Kyrgyzstan
1
Georgia
1
North America
1
Belgium
1
Tunisia
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
245
Clinical Guidelines
153
Pharmacy & Technologies
47
Public Health
24
Women & Child Health
23
Key Resources
18
Capacity Building
1
Toolboxes
COVID-19
157
TB
108
HIV
91
AMR
55
NTDs
44
Pharmacy
32
Ebola
29
Rapid Response
28
Zika
16
Caregiver
16
Planetary Health
15
Refugee
13
Mental Health
12
Polio
6
NCDs
6
Global Health Education
4
Conflict
3
Specific Hazards
3
Cholera
2
Natural Hazards
2
Disability
1
Social Ethics
1
The objectives of the meeting were:
1. To update the current status of the disease transmission, country capacities and plans for tackling the disease.
2. To understand the epidemiology including disease distribution and risk, the models
for estimating under-detection, the geographical variati...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download...
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where
health systems face signifi...
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as...
The Guidance on global monitoring for diabetes prevention and control by WHO provides a comprehensive framework to support countries in tracking and managing diabetes prevention, care, and outcomes. This document outlines indicators across 4 domains...
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expand...
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, ... response to requests from Member States, national programme managers and health workers for support to achieve the United Nations (UN) 90–90–90 global HIV targets – and specifically the first target of diagnosing 90% of all people with HIV. In 2016, based on new evidence, WHO released a supplement to address important new HIV testing approaches – HIV self-testing (HIVST) and provider-assisted referral.
Since the release of 2015 and 2016 HTS guidelines, new issues and more evidence have emerged. To address this, WHO has updated guidance on HIV testing services. In this guideline, WHO updates recommendation on HIVST and provides new recommendations on social network-based HIV testing approaches and western blotting (see box, next page). This guideline seeks to provide support to Member States, programme managers, health workers and other stakeholders seeking to achieve national and international goals to end the HIV epidemic as a public health threat by 2030.
These guidelines also provide operational guidance on HTS demand creation and messaging; implementation considerations for priority populations; HIV testing strategies for diagnosis HIV; optimizing the use of dual HIV/syphilis rapid diagnostic tests; and considerations for strategic planning and rationalizing resources such as optimal time points for maternal retesting
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt...
The objective of the 2022 Compendium is to compile and highlight emerging innovative health technologies for low-resource settings. It presents a snapshot of technologies that are solutions to an unmet medical/health technology need or are likely to improve health outcomes and the quality of life. H...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on ...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
This manual describes some of the strategic, managerial, financial, technical and scientific aspects to be considered in establishing a national EQA programme for clinical laboratories and other testing services at all health care levels
TNew data from the World Health Organization reveal that the COVID-19 pandemic has disrupted malaria services, leading to a marked increase in cases and deaths.
According to WHO’s latest World malaria report, there were an estimated 241 million m...
This resource consists of technical guidelines for District Medical Officers, counselors and laboratory technicians for second-line antiretroviral therapy drugs, operational guidelines for pilot roll-out in two centres and laboratory guidelines for ...
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response ... the event of an emergency. The document contains comprehensive guidelines for preparedness activities, biosafety and biosecurity measures, capacity development, specialised health care and laboratory facilities, strengthening of the existing legislative/
regulatory framework, mental health support, response, rehabilitation and recovery, etc. It specifically lays down the approach for implementation of the guidelines by the central ministries/departments, states, districts and other stakeholders, in a time bound manner.
Replacement of Annex 2 of WHO Technical Report Series, No. 964... minimizing mortality and morbidity. These preparations are included in the WHO List of Essential Medicines and should be part of any primary health care package where snakebites occur. Currently, there is an urgent need to ensure availability of safe, effective and affordable antivenoms, particularly to those in developing countries and to improve the regulatory control over the manufacture, import and sale of antivenoms.>
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resis...
